Cargando…

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

BACKGROUND: Cancer patients are considered highly vulnerable to the COVID-19 pandemic. However, delaying cancer-specific therapies could have a deleterious effect on survival. The potential suppressive effects of chemotherapies or cancer-related microenvironment raised the question on how cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansi, Laura, Spehner, Laurie, Daguindau, Etienne, Bouiller, Kevin, Almotlak, Hamadi, Stein, Ulrich, Bouard, Adeline, Kim, Stefano, Klajer, Elodie, Jary, Marine, Meynard, Guillaume, Vienot, Angélique, Nardin, Charlée, Bazan, Fernando, Lepiller, Quentin, Westeel, Virginie, Adotévi, Olivier, Borg, Christophe, Kroemer, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Current Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997727/ https://www.ncbi.nlm.nih.gov/pubmed/33882374 http://dx.doi.org/10.1016/j.ejca.2021.03.033

Ejemplares similares

Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
por: Orillard, Emeline, et al.
Publicado: (2022)

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age
por: Orillard, E., et al.
Publicado: (2023)

COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
por: Kroemer, Marie, et al.
Publicado: (2021)

FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
por: Vienot, Angélique, et al.
Publicado: (2020)

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
por: Kroemer, Marie, et al.
Publicado: (2020)

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T(H)1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
por: Rebucci-Peixoto, Magali, et al.
Publicado: (2022)

CD8(+) CD226(high) T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery
por: Viot, Julien, et al.
Publicado: (2023)

Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy
por: Vienot, Angélique, et al.
Publicado: (2022)

Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020)

Does type of immunosupression influence the course of Covid-19 infection?
por: Razanamahery, J., et al.
Publicado: (2020)

Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
por: Hervé, Laure, et al.
Publicado: (2022)

Present and Future Research on Anal Squamous Cell Carcinoma
por: Spehner, Laurie, et al.
Publicado: (2021)

TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition
por: Marguier, Amélie, et al.
Publicado: (2022)

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
por: Eberst, Guillaume, et al.
Publicado: (2022)

SALL4‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features
por: Vienot, Angélique, et al.
Publicado: (2023)

Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
por: Loyon, Romain, et al.
Publicado: (2019)

Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2020)

Epigenetic Reprogramming of CD4(+) Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
por: Renaude, Elodie, et al.
Publicado: (2021)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
por: Kroemer, Marie, et al.
Publicado: (2022)

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?
por: Abdeljaoued, Syrine, et al.
Publicado: (2022)

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial
por: Debernardi, Alice, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)
por: Tougeron, David, et al.
Publicado: (2021)

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
por: Kim, Stefano, et al.
Publicado: (2023)

Cholangiocarcinoma: the quest for a second-line systemic treatment
por: Vienot, Angélique, et al.
Publicado: (2019)

Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response
por: Razanamahery, J., et al.
Publicado: (2020)

Preserving women’s reproductive autonomy while promoting the rights of people with disabilities?: the case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany
por: Perrot, Adeline, et al.
Publicado: (2023)

Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
por: Kim, Stefano, et al.
Publicado: (2020)

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
por: Vrecko, Sindy, et al.
Publicado: (2018)

Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
por: Cordonnier, Marine, et al.
Publicado: (2020)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity
por: Poussard, Margaux, et al.
Publicado: (2020)

Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis
por: Nardin, Charlée, et al.
Publicado: (2018)

Nivolumab-induced capillary leak syndrome associated with chylothorax in a melanoma patient: A case report and review of the literature
por: Neuville, Carole, et al.
Publicado: (2022)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Immune Therapy for Liver Cancers
por: Hilmi, Marc, et al.
Publicado: (2019)

Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
por: Calcagno, Fabien, et al.
Publicado: (2016)

Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases
por: Bouiller, Kevin, et al.
Publicado: (2020)

A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience – Franche Comté, France
por: Gallais-Serezal, Irène, et al.
Publicado: (2021)

Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma
por: Grave, Athénaïs, et al.
Publicado: (2022)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fo03sgshn4d38kod9lni3hrjfm